These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24069611)

  • 1. The 2nd China Congress on Controversies to Consensus in Diabetes, Obesity, and Hypertension (CODHy).
    J Diabetes; 2013 Sep; 5(3):228-32. PubMed ID: 24069611
    [No Abstract]   [Full Text] [Related]  

  • 2. The Controversies in Obesity, Diabetes and Hypertension (CODHy) meeting: what is it all about?
    Raz I; Weiss R
    Diabetes Care; 2008 Feb; 31 Suppl 2():S111-2. PubMed ID: 18227469
    [No Abstract]   [Full Text] [Related]  

  • 3. Introduction to the 4th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy).
    Del Prato S; Raz I
    Diabetes Care; 2013 Aug; 36 Suppl 2(Suppl 2):S111-2. PubMed ID: 23882034
    [No Abstract]   [Full Text] [Related]  

  • 4. Introduction to the 5th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy).
    Raz I; Cefalu WT; Ilkova H; Del Prato S
    Diabetes Care; 2016 Aug; 39 Suppl 2(Suppl 2):S113-4. PubMed ID: 27440822
    [No Abstract]   [Full Text] [Related]  

  • 5. Introduction to the Second World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy): dilemmas in clinical practice.
    Raz I
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S149-50. PubMed ID: 19875542
    [No Abstract]   [Full Text] [Related]  

  • 6. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.
    Bozkurt B; Aguilar D; Deswal A; Dunbar SB; Francis GS; Horwich T; Jessup M; Kosiborod M; Pritchett AM; Ramasubbu K; Rosendorff C; Yancy C;
    Circulation; 2016 Dec; 134(23):e535-e578. PubMed ID: 27799274
    [No Abstract]   [Full Text] [Related]  

  • 7. Seventh World congress on controversies to consensus in diabetes, obesity, and hypertension.
    Kurian MJ; Rentzepis PJ; Carracher AM; Close KL
    J Diabetes; 2019 Aug; 11(8):628-631. PubMed ID: 31012279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expert consensus on blood pressure management of diabetic patients in China.
    Peng Y
    J Diabetes; 2014 May; 6(3):202-11. PubMed ID: 24164914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertensive therapy: Part II.
    Franco V; Oparil S; Carretero OA
    Circulation; 2004 Jun; 109(25):3081-8. PubMed ID: 15226224
    [No Abstract]   [Full Text] [Related]  

  • 10. Type 2 diabetes in Asia: where do we go from here?
    Soares M; Müller MJ
    Eur J Clin Nutr; 2017 Jul; 71(7):801-802. PubMed ID: 28677686
    [No Abstract]   [Full Text] [Related]  

  • 11. [Management of diabetes and hypertension: how do primary care physicians judge their performance?].
    Krause P; Wittchen HU; Küpper B; Pittrow D; Unger T; Sharma AM; Ritz E; Göke B; Lehnert H; Tschöpe D; Kirch W; Pfister H; Bramlage P; Höfler M
    Fortschr Med Orig; 2003 Feb; 121 Suppl 1():12-8. PubMed ID: 14732945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY.
    Garber AJ; Abrahamson MJ; Barzilay JI; Blonde L; Bloomgarden ZT; Bush MA; Dagogo-Jack S; DeFronzo RA; Einhorn D; Fonseca VA; Garber JR; Garvey WT; Grunberger G; Handelsman Y; Hirsch IB; Jellinger PS; McGill JB; Mechanick JI; Rosenblit PD; Umpierrez GE
    Endocr Pract; 2018 Jan; 24(1):91-120. PubMed ID: 29368965
    [No Abstract]   [Full Text] [Related]  

  • 13. Introduction to the Third World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy): outcome studies versus clinical experience in the treatment of diabetes.
    Raz I; Del Prato S
    Diabetes Care; 2011 May; 34 Suppl 2(Suppl 2):S99-100. PubMed ID: 21525487
    [No Abstract]   [Full Text] [Related]  

  • 14. Too many notes: up and down the scales of diabetes therapy.
    Vinik A
    Clin Ther; 2007; 29 Spec No():1227-35. PubMed ID: 18046924
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of lifestyle intervention on atrial fibrillation.
    Hong KL; Glover BM
    Curr Opin Cardiol; 2018 Jan; 33(1):14-19. PubMed ID: 29049041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Obesity in adults].
    Duodecim; 2004; 120(6):719-20. PubMed ID: 15119233
    [No Abstract]   [Full Text] [Related]  

  • 17. Break the "HOLD": The Need to Strengthen the Management of Hypertension, Obesity, Lipids, and Diabetes (HOLD) and Improve Cardiovascular Health in People With Diabetes.
    Abushamat LA; Nambi V
    J Am Heart Assoc; 2023 May; 12(10):e029944. PubMed ID: 37183835
    [No Abstract]   [Full Text] [Related]  

  • 18. Obesity: an emerging disease.
    Ogunbode AM; Ladipo M; Ajayi IO; Fatiregun AA
    Niger J Clin Pract; 2011; 14(4):390-4. PubMed ID: 22248935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes therapy--focus on Asia: second-line therapy debate: insulin/secretagogues.
    Eldor R; Raz I
    Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():85-9. PubMed ID: 23280872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American Diabetes Association annual meeting 1996: the etiology of type II diabetes, obesity, and the treatment of type II diabetes.
    Bloomgarden ZT
    Diabetes Care; 1996 Nov; 19(11):1311-5. PubMed ID: 8908409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.